Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherReceivables RefundsShares OutstandingShares OutstandingShort-Term Debt repayments
Ratios

BioNexus Gene Lab (BGLC) Other Gross PP&E Adjustments (2019 - 2025)

BioNexus Gene Lab's Other Gross PP&E Adjustments history spans 7 years, with the latest figure at $2.4 million for Q4 2025.

  • Quarterly results put Other Gross PP&E Adjustments at $2.4 million for Q4 2025, up 3.25% from a year ago — trailing twelve months through Dec 2025 was $2.4 million (up 3.25% YoY), and the annual figure for FY2025 was $2.4 million, up 3.25%.
  • Other Gross PP&E Adjustments for Q4 2025 was $2.4 million at BioNexus Gene Lab, roughly flat from $2.4 million in the prior quarter.
  • In the past five years, Other Gross PP&E Adjustments ranged from a high of $2.4 million in Q4 2025 to a low of $31214.0 in Q1 2021.
  • The 5-year median for Other Gross PP&E Adjustments is $2.2 million (2022), against an average of $1.7 million.
  • The sharpest move saw Other Gross PP&E Adjustments surged 4728.66% in 2021, then crashed 97.62% in 2022.
  • Year by year, Other Gross PP&E Adjustments stood at $2.2 million in 2021, then crashed by 97.62% to $51684.0 in 2022, then soared by 4263.2% to $2.3 million in 2023, then rose by 1.59% to $2.3 million in 2024, then rose by 3.25% to $2.4 million in 2025.
  • According to Business Quant data, Other Gross PP&E Adjustments over the past three periods came in at $2.4 million, $2.4 million, and $2.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.